Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years

NCT00464217 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloblastic Leukaemia

Interventions

DRUG: ARA-C
DRUG: Idarubicin
DRUG: Leucomax

Sponsor

PETHEMA Foundation